This retrospective assessment showed that AURKA and MYCN amplifications in primary adeno-PC effectively predict for a late-stage development of NEPC in CRPC patients also suggesting these molecular alterations may predispose for development of the small-cell disease from adeno-PC. The gene discussed is MYCN; the disease is pachyonychia congenita.